CCAP Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -4.84%, SMA50 -7.39%, SMA200 -9.28%). The stock’s 14-day RSI is 35.63 (weak momentum), while the ATR of 0.38 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -28.33% below its high and over 4.09% above its low. Average 10-day trading volume of 252.85 thousand shares is in line with the 3-month average of 246.68 thousand, indicating normal recent market interest.

Crescent Capital BDC, Inc. (NASDAQ:CCAP) closed at $11.16 USD, gaining $0.20 (1.82%) from the previous close of $10.96. The stock is currently within 5% of its 52-week low $10.77 and $16.04. With a market capitalization of about $411.20 million, Crescent Capital BDC, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.58). Key stats such as the average daily volume over the past year has been around 243.09 thousand shares, volume is running light vs its 52-week average. Headquartered in Los Angeles, CA, Crescent Capital BDC, Inc. operates in the Financial Services sector and the Asset Management industry. Led by CEO Jason A. Breaux, the company employs approximately 250 people and listed since February 03, 2020. Crescent Capital BDC, Inc. functions as a Business Development Company (BDC), managing a fund dedicated to private equity, leveraged buyouts, and providing loan capital.

Crescent Capital BDC, Inc. generated EPS of $0.97 over the past year. Five-year average earnings growth is 3.29%. The latest quarter delivered EPS of $0.42. The next quarter is forecast at $0.39. Next year's EPS is expected at -$0.55. Analyst sentiment is neutral. Analyst rating data shows there are 4 Strong Buy ratings, 2 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $19.00 to $12.00. The high target offers 73.36% upside. The low target suggests 9.49% downside. The mean target is $14.86. This offers 35.58% upside. Crescent Capital BDC, Inc. earnings surprise history is a mixed track record. The quarter that ended May 13, 2026, missed forecasts by 2.44%. The prior quarter beat by 2.27%. Over the last six quarters, Apple has recorded several small beats. These include -1.79% in February 19, 2025.

Our AI price prediction model suggests that Crescent Capital BDC, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.46%, with price expected at $11.01 by July 31, 2026, within a range of $10.86 to $11.14 3-Month Outlook: Projected fall of -10.22%, reaching $9.84 by October 12, 2026, with a range of $9.37 to $10.26. 1-Year Outlook: Projected loss of -10.31%, with price at $9.83 by July 20, 2027, within a range of $0.00 to $11.83.

Crescent Capital BDC, Inc. (NASDAQ:CCAP) shares are flat 2.63% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Crescent Capital BDC, Inc. trading at a premium to the broader market with a P/E of 27.15. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $17.09, suggesting 55.93% upside. Our AI forecast model points to short-term strength (0.46% over two weeks), a medium-term fall (-10.22% over three months), and a longer-term loss (-10.31% over one year), with expected trading ranges indicating moderate volatility.

Crescent Capital BDC, Inc. last paid a dividend of 1.68 per share, this equals a trailing yield of roughly 11.95%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $41.23. This means the shares are trading below this model’s fair value.

Crescent Capital BDC, Inc. trades at a P/E ratio of 27.15, slightly below the S&P 500 average, with a price-to-sales ratio of 3.29 and a price-to-book ratio of 0.61 suggesting the stock is closer to book value. The P/FCF stands at 6.21, also below market averages.